MedPath

The purpose of the study is to evaluate safety and performance of Eye Preparations - Sodium Chloride Eye Drop (0.75%) (Calendula extract plus Hamamelis extract

Not Applicable
Completed
Conditions
Cataract in diseases classified elsewhere,
Registration Number
CTRI/2022/07/043790
Lead Sponsor
STERICON PHARMA PRIVATE LIMITED
Brief Summary

A post market clinical follow up prospective study to evaluate safety and performance of Eye Preparations (Sodium Chloride Eye Drop (0.75%) (Calendula extract + Hamamelis extract**)**.

Sodium Chloride 0.75% Eye drops with calendula + Hamamelis extract  are used to relieve eye discomfort and soreness due to environmental factors Polyhexamethylene biguanide binds to the negatively charged phospholipids found in the microbial plasma membranes causing membrane disruption and cellular lysis. Disodium edetate is a cationic chelating agent that binds free metals and enhances antimicrobial activity of disinfectants. Calendula is having anti-inflammatory properties that help to reduce the irritation of eyes caused by pollutants. It is effective against itching and inflammations of eyes. Hamamelis water is used for external eye preparations such as eye drops and eye wash. It is a Traditional herbal medicinal product for the temporary relief of discomfort due to continuous exposure to wind and sun. Sodium chloride is an electrolyte added to maintain osmolarity as high osmolarity products pull water from epithelial cells.

 Sodium Chloride Eye Drop (0.75%) (Calendula extract + Hamamelis extract can be used to protect the eye from irritations/dryness/discomfort due to continuous use of computer/TV/exposed pollution/dry environment and use of contact lenses.

There will be 4 follow up visits expected after using the product:

1st Visit - After 8 days of using the product

2nd Visit - After one month of using the product

3rd Visit - After two months of using the product

4th Visit - After three months of using the product

| | |

| --- | --- |

|Intended purpose

Persons who experience irritation, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment use the eye drop with herbal extract to soothe the eyes.

|Intended users

Persons who experience irritation/ itchiness/discomfort of eyes due to the continuous use of computer/TV/ exposed pollution /dry environment.

This study will be a prospective, multi-centric, non-randomized study. The subjects visiting the study centers with the complaints such as eye dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment will be screened at Day 0 and if they meet the inclusion and exclusion criteria, then they will be selected for the study. A total of 72 subjects will be recruited for this study for the Sodium Chloride Eye Drop (0.75%) (Calendula extract + Hamamelis extract).

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
72
Inclusion Criteria
  • At the time of screening and usage of the product all subjects must meet the following criteria for inclusion into the study and the subjects will receive the prescribed eye drops with herbal extract from the PI/CO-I by a medical practitioner.
  • The inclusion criteria for the subjects for this study are as follows: -Subjects who experience, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment -Subjects wearing contact lenses who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment.
Exclusion Criteria

The below Subjects are excluded from the study: -Subjects who are not willing to participate in the study -Anyone with known allergic reaction to Sodium Chloride Eye Drop (0.75%) (Calendula extract + Hamamelis extract) -Subjects with any existing eye infection -Subjects undergone recent (6weeks) cataract surgery who are on other eye medication.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective is to confirm clinical safety and performance of the product Sodium Chloride Eye Drop (0.75%) (Calendula extract + Hamamelis extract) by performing a set of eye examinations (i.e.visual acuity test, IOP measurement, corneal staining, Schirmer’s test considering the baseline from the initial visit and obtained during the follow up visits. If the end user is a contact lens wearer contact lens characteristics will also be measured at the end of the study1st Visit - After 8 days of using the product | 2nd Visit - After one month of using the product | 3rd Visit - After two months of using the product | 4th Visit - After three months of using the product
Secondary Outcome Measures
NameTimeMethod
The secondary objective is to assess any emerging undesirable events along with monitoring of desired events, contraindications, residual risk, emerging risk under normal usage of the eye drops with herbal extract for prolonged period to ensure acceptability of benefit risk ratio of the eye drop with herbal extract, which will be recorded in CRF during every follow up visit based on the subject rating. The study will be focused on identifying possible systematic misuse or off-label use of the device1st Visit - After 8 days of using the product

Trial Locations

Locations (1)

Vivekananda Eye Hospital, Bengaluru, Karnataka

🇮🇳

Bangalore, KARNATAKA, India

Vivekananda Eye Hospital, Bengaluru, Karnataka
🇮🇳Bangalore, KARNATAKA, India
Dr Chethan S Sadanand
Principal investigator
9600122287
chethan.sadanand@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.